
FDMT
USD4D Molecular Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$11.020
고가
$11.020
저가
$10.040
거래량
0.63M
기업 기본 정보
시가총액
578.4M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.80M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global registration Up to $336
RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target
RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics with a Outperform and maintains $26 price target.
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with
관련 주식
EXAI
Exscientia Plc American Depositary Shares
OZKAP
Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock
VTYX
Ventyx Biosciences Inc.
UHS
Universal Health Services
ECAT
BlackRock ESG Capital Allocation Term Trust Common Shares of Beneficial Interest
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기